Unlock instant, AI-driven research and patent intelligence for your innovation.

Bionic anti-tumor nano-drug and preparation method thereof

An anti-tumor drug and nano-drug technology, applied in the field of anti-tumor drugs, can solve problems such as limiting the probability of anti-tumor nano-drugs entering the tumor center, the transport efficiency of anti-tumor nano-drugs not exceeding 1%, and limiting clinical therapeutic effects and applications. , to achieve good anti-tumor effect, high delivery efficiency, good biological safety effect

Inactive Publication Date: 2021-06-04
YANSHAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, the transport efficiency of anti-tumor nano-drugs does not exceed 1%, which greatly limits its clinical therapeutic effect and application.
The tumor pressure around the tumor tissue will form a natural physical barrier that severely limits the chance of anti-tumor nanomedicines entering the tumor center
The tumor site lacks lymphatic drainage, and the interstitial fluid in the tumor tissue is retained to form a high tumor interstitial fluid pressure (TIFP). High TIFP will limit blood perfusion to the tumor tissue, thereby limiting the convective diffusion of anti-tumor nano-medicines with blood. Small amounts of antitumor nanomedicine spread to tumor margins

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bionic anti-tumor nano-drug and preparation method thereof
  • Bionic anti-tumor nano-drug and preparation method thereof
  • Bionic anti-tumor nano-drug and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 20g melamine (purchased from Aladdin Reagent Company) was roasted at 550°C for 2 hours to obtain white g-C 3 N 4 , and then roasted at 550°C for 2h to obtain light yellow g-C 3 N 4 Precursor, finally calcined at 550°C for 2h to obtain white g-C 3 N 4 nanoflakes, followed by photodeposition of Pt on g-C 3 N 4 Surface made g-C 3 N 4 -Pt nanosheets. 1 mg gray g-C 3 N 4 - Pt flakes were dispersed under pH 7.4 phosphate buffer and ultrasonic conditions for 30 minutes, 1 mg of paclitaxel was added to the above solution and mixed, and then 1 mL of bisoxalate sodium bicarbonate was slowly added to the mixed solution under magnetic stirring at room temperature solution (0.5mg / mL), to obtain paclitaxel / g-C 3 N 4 - Pt / bisoxalate (PCC) nanosheets. After 1 hour, the cell membranes of macrophages and PCC were shaken in an air bath at 40°C for 15 hours. The obtained biomimetic anti-tumor nanomedicine (PCC@M) was resuspended in pH7.4 phosphate buffer, extruded 15 times wi...

Embodiment 2

[0034] Roast 25g of melamine at 400°C for 4 hours to obtain white g-C 3 N 4 , and then roasted at 400°C for 2h to obtain light yellow g-C 3 N 4 Precursor, finally calcined at 400°C for 2h to obtain white g-C 3 N 4 nanoflakes, followed by photodeposition of Pt on g-C 3 N 4 Surface made g-C 3 N 4 -Pt nanosheets. 1mg gray g-C 3 N 4 - Pt flakes were dispersed in phosphate buffer and ultrasound for 30 minutes, 1 mg of paclitaxel was added to the above solution and mixed, then 2 mL of luminol solution (0.8 mg / mL) was slowly added to the mixed solution at room temperature under magnetic stirring, get paclitaxel / g-C 3 N 4 - Pt / luminol nanosheets (PCL). After 1 hour, the macrophage membranes and PCL were shaken in an air bath at 40 °C for 12 hours. Resuspend the obtained biomimetic nanomedicine with phosphate buffer, extrude it 15 times with a liposome extruder, centrifuge at 10,000 rpm for 1 hour, take the precipitate and resuspend it with phosphate buffer to obtain PCL@...

Embodiment 3

[0037] Roast 25g of melamine at 550°C for 4 hours to obtain white g-C 3 N 4 , and then roasted at 500°C for 2h to obtain light yellow g-C 3 N 4 Precursor, finally calcined at 500°C for 2h to obtain white g-C 3 N 4 nanoflakes, followed by photodeposition of Pt on g-C 3 N 4 Surface made g-C 3 N 4 -Pt nanosheets. 1mg gray g-C 3 N 4 -Pt flakes were dispersed in phosphate buffer and ultrasonic for 30 minutes, 1 mg of paclitaxel was added to the above solution and mixed, and then 1 mL of bisoxalate sodium bicarbonate solution (0.3 mg / mL), to get paclitaxel / g-C 3 N 4 -Pt / bisoxalate nanosheets. After 1 hour, shake the macrophage membrane and PCC in an air bath at 40°C for 12 hours. The resulting biomimetic anti-tumor nanomedicine (PCC@M) was resuspended in phosphate buffer, then extruded 15 times with a liposome extruder, centrifuged at 10,000rpm for 1 hour, and the precipitate was resuspended in phosphate buffer , stored at 4°C.

[0038] The water-splitting performan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a bionic anti-tumor nano-drug and a preparation method thereof, and belongs to the technical field of anti-tumor drugs. The bionic anti-tumor nano-drug comprises an anti-tumor drug, a photolysis water catalyst, a cocatalyst, a chemiluminescence agent and a bionic cell membrane, wherein the anti-tumor drug, the photolysis water catalyst, the cocatalyst and the chemiluminescence agent are coated with the bionic cell membrane. The preparation method comprises the following two steps of: (1) preparing graphite phase carbon nitride; and (2) synthesizing the bionic anti-tumor nano-drug. The bionic anti-tumor nano-drug can significantly reduce the TIFP level through chemiluminescence-mediated water splitting, and improves the administration efficiency with the reduction of the TIFP level and the active targeting effect of a macrophage membrane; and at the same time, the bionic anti-tumor nano-drug has good chemotherapeutic drug loading, and can effectively realize the synergistic treatment of hydrodynamic therapy and chemotherapy.

Description

technical field [0001] The invention relates to a bionic anti-tumor nano drug and a preparation method thereof, belonging to the technical field of anti-tumor drugs. Background technique [0002] At present, the transport efficiency of anti-tumor nano-drugs does not exceed 1%, which greatly limits its clinical therapeutic effect and application. The tumor pressure around the tumor tissue will form a natural physical barrier that severely limits the chance of anti-tumor nanomedicines entering the tumor center. The tumor site lacks lymphatic drainage, and the interstitial fluid in the tumor tissue is retained to form a high tumor interstitial fluid pressure (TIFP). High TIFP will limit blood perfusion to the tumor tissue, thereby limiting the convective diffusion of anti-tumor nano-medicines with blood. A small amount of antitumor nanomedicine spread to the tumor margin. In addition, due to the blockage of blood flow in the tumor center, it is difficult to deliver drugs into...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K41/00A61P35/00A61K31/704A61K31/337
CPCA61K31/337A61K31/704A61K41/0057A61P35/00A61K2300/00
Inventor 高大威丛聪卞佳鑫李春慧
Owner YANSHAN UNIV